Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.

Clin Exp Nephrol. 2018 Jul 23. doi: 10.1007/s10157-018-1610-2. [Epub ahead of print]

PMID:
30039480
2.

Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.

Clin Exp Nephrol. 2018 Jun 29. doi: 10.1007/s10157-018-1609-8. [Epub ahead of print]

PMID:
29959568
3.

Multiband Imaging CMOS Image Sensor with Multi-Storied Photodiode Structure .

Takemoto Y, Tsukimura M, Kato H, Suzuki S, Aoki J, Kondo T, Saito H, Gomi Y, Matsuda S, Tadaki Y.

Sensors (Basel). 2018 May 24;18(6). pii: E1688. doi: 10.3390/s18061688.

4.

Undoped Layered Perovskite Oxynitride Li2 LaTa2 O6 N for Photocatalytic CO2 Reduction with Visible Light.

Oshima T, Ichibha T, Qin KS, Muraoka K, Vequizo JJM, Hibino K, Kuriki R, Yamashita S, Hongo K, Uchiyama T, Fujii K, Lu D, Maezono R, Yamakata A, Kato H, Kimoto K, Yashima M, Uchimoto Y, Kakihana M, Ishitani O, Kageyama H, Maeda K.

Angew Chem Int Ed Engl. 2018 Jul 2;57(27):8154-8158. doi: 10.1002/anie.201803931. Epub 2018 May 30.

5.

Functional splicing analysis in an infantile case of atypical hemolytic uremic syndrome caused by digenic mutations in C3 and MCP genes.

Yamamura T, Nozu K, Ueda H, Fujimaru R, Hisatomi R, Yoshida Y, Kato H, Nangaku M, Miyata T, Sawai T, Minamikawa S, Kaito H, Matsuo M, Iijima K.

J Hum Genet. 2018 Jun;63(6):755-759. doi: 10.1038/s10038-018-0436-9. Epub 2018 Mar 19.

PMID:
29556035
6.

[Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].

Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.

Rinsho Ketsueki. 2018;59(2):182-186. doi: 10.11406/rinketsu.59.182. Japanese.

PMID:
29515071
7.

Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.

Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M.

Clin Exp Nephrol. 2018 Oct;22(5):1088-1099. doi: 10.1007/s10157-018-1549-3. Epub 2018 Mar 6.

PMID:
29511899
8.

The response of common marmoset immunity against cedar pollen extract.

Kametani Y, Yamada Y, Takabayashi S, Kato H, Ishiwata K, Watanabe N, Sasaki E, Habu S.

Biosci Trends. 2018 Mar 18;12(1):94-101. doi: 10.5582/bst.2017.01219. Epub 2018 Jan 15.

9.

Controversies of the classification of TMA and the terminology of aHUS.

Kato H, Nangaku M, Okada H, Kagami S.

Clin Exp Nephrol. 2018 Aug;22(4):979-980. doi: 10.1007/s10157-017-1524-4. Epub 2017 Dec 27. No abstract available.

PMID:
29282571
10.

Effects of the SrTiO3 support on visible-light water oxidation with Co3O4 nanoparticles.

Okazaki M, Eguchi M, Uchiyama T, Lu D, Kato H, Uchimoto Y, Kakihana M, Maeda K.

Dalton Trans. 2017 Dec 12;46(48):16959-16966. doi: 10.1039/c7dt03444j.

PMID:
29177327
11.

Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):85-86. doi: 10.1007/s10157-017-1461-2. No abstract available.

PMID:
28875480
12.

Low signal intensity lesions on brain susceptibility-weighted MRI in a patient with intravascular large B-cell lymphoma.

Tsuda Y, Oguri T, Sakurai K, Kajiguchi T, Kato H, Yuasa H.

Rinsho Shinkeigaku. 2017 Sep 30;57(9):504-508. doi: 10.5692/clinicalneurol.cn-001027. Epub 2017 Aug 11. Japanese.

PMID:
28804112
13.

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):78-84. doi: 10.1007/s10157-017-1427-4. Epub 2017 Jun 28. Erratum in: Clin Exp Nephrol. 2017 Sep 5;:.

14.

Three cases of posterior reversible encephalopathy syndrome with chronic kidney disease triggered by infection.

Nasu K, Fujisawa M, Kato H, Nangaku M.

Nephrology (Carlton). 2017 Apr;22(4):322-325. doi: 10.1111/nep.12930.

PMID:
28247519
15.

Positron emission tomography in the diagnosis of cyst infections.

Hasegawa S, Kato H, Hamasaki Y, Koiwa T, Nangaku M.

Kidney Int. 2017 Mar;91(3):759. doi: 10.1016/j.kint.2016.10.025. No abstract available.

PMID:
28202176
16.

Cobalt Oxide Nanoclusters on Rutile Titania as Bifunctional Units for Water Oxidation Catalysis and Visible Light Absorption: Understanding the Structure-Activity Relationship.

Maeda K, Ishimaki K, Okazaki M, Kanazawa T, Lu D, Nozawa S, Kato H, Kakihana M.

ACS Appl Mater Interfaces. 2017 Feb 22;9(7):6114-6122. doi: 10.1021/acsami.6b15804. Epub 2017 Feb 7.

PMID:
28117578
17.

The Difference in Backscatter Factors of Diagnostic X-rays by the Difference in the Scattering Medium and in the Objective Dose.

Kato H, Sakai K, Uchiyama M, Suzuki K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2016;72(10):1007-1014. Japanese.

18.

A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes.

Kato H, Kokunai Y, Dalle C, Kubota T, Madokoro Y, Yuasa H, Uchida Y, Ikeda T, Mochizuki H, Nicole S, Fontaine B, Takahashi MP, Mitake S.

J Neurol Sci. 2016 Oct 15;369:254-258. doi: 10.1016/j.jns.2016.08.030. Epub 2016 Aug 13.

PMID:
27653901
19.

Clinical guides for atypical hemolytic uremic syndrome in Japan.

Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S; Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan.

Pediatr Int. 2016 Jul;58(7):549-55. doi: 10.1111/ped.13044.

PMID:
27460397
20.

Clinical guides for atypical hemolytic uremic syndrome in Japan.

Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S; Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan.

Clin Exp Nephrol. 2016 Aug;20(4):536-543. doi: 10.1007/s10157-016-1276-6. Review.

PMID:
27422619

Supplemental Content

Loading ...
Support Center